ION-827359
- Generic Name
- ION-827359
A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)
Phase 2
Terminated
- Conditions
- Chronic BronchitisChronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04441788
- Locations
- 🇩🇪
MECS Research GmbH, Berlin, Germany
🇩🇪Pneumologisches Studienzentrum Markgrafenstrasse, Berlin, Germany
🇩🇪Hamburger Institut far Therapieforschung GmbH, Hamburg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath